151 related articles for article (PubMed ID: 23250689)
1. [Longterm treatment with Risperidone in Alzheimer's disease? No justification for more "drug deaths" in nursing homes!].
Förstl H
Dtsch Med Wochenschr; 2013 Jan; 138(1-2):16. PubMed ID: 23250689
[No Abstract] [Full Text] [Related]
2. Discontinuation of risperidone in Alzheimer's disease.
Ling SM; Bonner AF; McMullen TL
N Engl J Med; 2013 Jan; 368(2):187. PubMed ID: 23301740
[No Abstract] [Full Text] [Related]
3. Discontinuation of risperidone in Alzheimer's disease.
Power GA
N Engl J Med; 2013 Jan; 368(2):186-7. PubMed ID: 23301739
[No Abstract] [Full Text] [Related]
4. Discontinuation of risperidone in Alzheimer's disease.
Gnjidic D; Hilmer SN
N Engl J Med; 2013 Jan; 368(2):186. PubMed ID: 23301738
[No Abstract] [Full Text] [Related]
5. Discontinuation of risperidone in Alzheimer's disease.
Devanand DP; Schultz SK; Sultzer DL
N Engl J Med; 2013 Jan; 368(2):187-8. PubMed ID: 23301737
[No Abstract] [Full Text] [Related]
6. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
7. Relapse risk after discontinuation of risperidone in Alzheimer's disease.
Devanand DP; Mintzer J; Schultz SK; Andrews HF; Sultzer DL; de la Pena D; Gupta S; Colon S; Schimming C; Pelton GH; Levin B
N Engl J Med; 2012 Oct; 367(16):1497-507. PubMed ID: 23075176
[TBL] [Abstract][Full Text] [Related]
8. The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease.
Creese B; Da Silva MV; Johar I; Ballard C
Expert Rev Neurother; 2018 Jun; 18(6):461-467. PubMed ID: 29764230
[TBL] [Abstract][Full Text] [Related]
9. Risperidone for Psychosis-Induced Aggression or Agitation.
Scruth E
Issues Ment Health Nurs; 2019 Nov; 40(11):988-989. PubMed ID: 31381459
[No Abstract] [Full Text] [Related]
10. Duration of risperidone treatment for BPSD.
Snowdon J; Brodaty H; Ames D; Day S
Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
[No Abstract] [Full Text] [Related]
11. Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.
Holmes C; Wilkinson D; Dean C; Clare C; El-Okl M; Hensford C; Moghul S
Int J Geriatr Psychiatry; 2007 Apr; 22(4):380-1. PubMed ID: 17380475
[No Abstract] [Full Text] [Related]
12. Liquid risperidone in the treatment of psychotic agitation.
Tsai C; Puzantian T
CNS Drugs; 2002; 16(11):777; author reply 778. PubMed ID: 12383033
[No Abstract] [Full Text] [Related]
13. Antipsychotic treatment of psychosis and agitation in the elderly.
Daniel DG
J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
[TBL] [Abstract][Full Text] [Related]
14. Treating behavioral and psychological symptoms in patients with psychosis of Alzheimer's disease using risperidone.
Rabinowitz J; Katz I; De Deyn PP; Greenspan A; Brodaty H
Int Psychogeriatr; 2007 Apr; 19(2):227-40. PubMed ID: 16879763
[TBL] [Abstract][Full Text] [Related]
15. Challenges in estimating mortality risk from antipsychotics in people with Alzheimer's disease.
Carnahan RM
Am J Psychiatry; 2014 Feb; 171(2):227. PubMed ID: 24500460
[No Abstract] [Full Text] [Related]
16. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
Ballard C; Waite J
Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
[TBL] [Abstract][Full Text] [Related]
17. To treat or not to treat? Managing acute symptoms in an elderly patient with Alzheimer's disease.
Deegan R; Bailey KP
J Psychosoc Nurs Ment Health Serv; 2001 Oct; 39(10):12-5. PubMed ID: 11697070
[No Abstract] [Full Text] [Related]
18. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.
Schneider LS; Tariot PN; Lyketsos CG; Dagerman KS; Davis KL; Davis S; Hsiao JK; Jeste DV; Katz IR; Olin JT; Pollock BG; Rabins PV; Rosenheck RA; Small GW; Lebowitz B; Lieberman JA
Am J Geriatr Psychiatry; 2001; 9(4):346-60. PubMed ID: 11739062
[TBL] [Abstract][Full Text] [Related]
19. Consequences of antipsychotic medications for the dementia patient.
Devanand DP; Schultz SK
Am J Psychiatry; 2011 Aug; 168(8):767-9. PubMed ID: 21813491
[No Abstract] [Full Text] [Related]
20. Psychosis, agitation, and antipsychotic treatment in dementia.
Devanand DP
Am J Psychiatry; 2013 Sep; 170(9):957-60. PubMed ID: 24030608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
